| |
Home »
Medical Search » Medical Briefings »
A Tour around Leptospirosis
A Tour around Leptospirosis
Read more about
Leptospirosis
A Tour around Leptospirosis
(Date of publication 13
August 2004) Britain's rats are currently enjoying a somewhat pampered
existence, and their numbers are increasing accordingly - not surprising when a
single pair can produce a colony of 2,000 within a year. Today the UK plays
host to more than 60 million of them. The causes of their
proliferation include mild winters, a cutback in expenditure on pest control
and the increased discarding of junk food in the street. One reason this
population explosion is important is that feral rats are the main animal
reservoir for Leptospira interrogans, the causative organism of
leptospirosis, which is occasionally fatal. About 30 cases
occur each year in Britain. Warnings about
rat numbers
were issued by the National Pest Technicians Association as long ago as
November 2000, a year after high concentrations of the bacteria were found at
stations on Glasgow's subway system.
Leptospira interrogans is
a flexible, spiral-shaped, Gram-negative spirochaete with internal flagella
(see this
scanning electron micrograph) . There are more than 200 serovars, classified according to cell
surface antigens, of which Icterohaemorrhagiae is most frequently
associated with severe infection. Long chain fatty acids are this pathogen's
sole major energy source, and it is unique in being able to grow at
temperatures as low as 11°C to 13°C.
Infection predominantly occurs via contact with rat urine,
or water containing it, either by ingestion or through broken skin. The
bacterium is unable to survive for more than an hour unless immersed in water
or urine, and does not multiply once it has left the host. Thus leptospirosis
is relatively difficult to catch, but swimming, canoeing, fishing, sailing,
windsurfing or water-skiing in fresh water - and caving - are associated with a
high risk. The precautions which should be taken to minimise the chances of
infection are covered extensively
here.
Brief details about the disease can be found
(buried amongst a profusion of advertisements!) at
this site. Most cases are not severe and comprise two
phases: during the first phase the patient experiences fever, chills, muscle
and abdominal pain, and severe headache. After one to three days of
improvement, these symptoms re-appear during the second phase, along with eye
pain, rash and enlarged lymph glands. As explained about halfway down
this
page, the first phase coincides with bacteraemia. Once antileptospiral
antibodies appear, the acute phase subsides and bacteria can no longer be
isolated from the blood. The second phase of the disease corresponds with the
host's immunological response, when the bacteria are rapidly eliminated from
all tissues except the brain, eyes and kidneys. Those in the brain and eyes do
not proliferate, but in the kidney they multiply and are shed in the urine. A
photograph of an infected kidney can be seen
here, and a kidney section showing an inflammatory cell
infiltrate and the damage to tubular epithelial cells
here.
The severe form of leptospirosis is termed
Weil's Syndrome and may be fatal in 5% of cases. Characteristic features are
mental involvement, low blood pressure, fever, and renal and hepatic
dysfunction. The disease-causing mechanism is not known, but the contrast
between the level of functional impairment and the scarcity of histological
lesions suggests that most damage occurs at the subcellular level.
A
notably comprehensive account of leptospirosis is available on the
emedicine
site, which also has some interesting facts. This disease is the most
common zoonosis in the world, and also glories in the wonderfully attractive
name of 'swamp fever'. At least 160 mammalian species can be affected.
Approximately 90% of human patients have the mild anicteric (without jaundice)
form of the disease, and many (77%) have an intense headache during the second
phase which is poorly controlled by analgesics and often heralds the onset of
aseptic meningitis.
The most common ocular complication is
subconjunctival haemorrhage (an extreme example is shown
here). Uveitis (inflammation of the iris, ciliary body or
choroid) may occur at any stage of the disease and is usually classified by the
part of the eye that is affected; the signs and symptoms of the different
categories are described in the
Merck Manual.
In severe cases of leptospirosis,
liver involvement may lead to jaundice, with its yellow coloration of the skin,
eyes and mucous membranes that results from an accumulation of bilirubin, a
product of the breakdown of red blood cells. The condition is outlined briefly
at
this site and
the photograph of an
eye leaves little doubt about the diagnosis. Much more
information about jaundice is available
here, including the significance of whether the excess
bilirubin is in the conjugated (and therefore water-soluble) or unconjugated
form.
Renal symptoms such as pyuria, haematuria and oliguria are seen
in 50% of patients. Acute tubular necrosis may occur in sufferers from Weil's
Syndrome as a result of hypovolaemia and decreased renal perfusion, and those
with severe jaundice are more likely to develop acute renal failure. This is
defined as a precipitous and significant (>50%) decrease in the glomerular
filtration rate. It constitutes a medical emergency, may require dialysis, and
has a significant mortality rate. For all you want to know on the topic, surf
to this
site.
Finally, the good news is that most patients with
leptospirosis recover and those with hepatic symptoms and renal failure have a
good chance of regaining normal function. The mild form of the disease is
treated with doxycycline, ampicillin or amoxicillin, and the severe form with
penicillin G. Obviously prevention is better than cure, but balancing the risk
of infection against the pleasure derived from water-based pastimes is not an
easy task...
Read more about
Leptospirosis
|
This medical briefing
was written by Derrick Garwood, a Freelance Medical Writer and Editor, and
first published, on this same date, in the series of InPharm Tours at
InPharm.com. It is
reproduced here with permission from the publishers.
The links
presented here were accurate at the time of publication, but remember that
information on the Web has a tendancy to change without notice! |
Disclaimer
Net Media Marketing excludes any
warranty, express or implied, as to the quality, accuracy, timeliness,
completeness or fitness for a particular purpose of this briefing. Net Media
Marketing will not be liable for any claims, penalties, losses, damages, costs,
or expenses arising from the use of or inability to use this briefing or from
any unauthorised access to or alteration of the Briefing. Net Media Marketing
makes no warranty that the contents of this briefing are compatible with all
computer systems and browsers.
Pharmaceutical Jobs, All
jobs & Vacancies, Pharmaceutical sales jobs,
Healthcare sales jobs,
Laboratory sales jobs,
Veterinary sales jobs,
Dental sales jobs,
Trainee
medical sales jobs, Nurse Advisor
jobs, Sales Management
jobs, Marketing
jobs, Senior Management
jobs, Regulatory &
Clinical jobs, Scientific Sales
Jobs, British National Formulary (BNF),
British Pharmacopoeia
(BP)
|